Showing results (201-210 of 2,355) with videos related to
Sort By:
Pageof 236
Clinical Neuropharmacology|April 24, 2010
Factors associated with motor fluctuations and dyskinesia in Parkinson Disease: potential role of a new melevodopa plus carbidopa formulation (Sirio)Fabrizio Stocchi, Stefano MarconiClinical Neuropharmacology|August 1, 2009
Efficacy and safety of botulinum neurotoxin NT 201 in poststroke upper limb spasticityPetr Kanovský, Jaroslaw Slawek, Zoltan Denes, et al.Clinical Neuropharmacology|June 2, 2009
Update on inflammation, neurodegeneration, and immunoregulation in multiple sclerosis: therapeutic implicationsJeffrey L Bennett, Olaf StüveClinical Neuropharmacology|June 2, 2009
Syndrome of inappropriate antidiuretic hormone secretion possibly associated with amantadine therapy in Parkinson diseaseHortensia Alonso Navarro, Angel Sánz-Aiz, Laura Izquierdo, et al.Clinical Neuropharmacology|June 11, 2009
Treatment of acquired periodic alternating nystagmus with memantine: a case reportAnil Kumar, Shery Thomas, Rebecca McLean, et al.Clinical Neuropharmacology|October 7, 2008
The effects of guanfacine on working memory performance in patients with localization-related epilepsy and healthy controlsBarbara E Swartz, Carrie R McDonald, Ashok Patel, et al.Clinical Neuropharmacology|October 7, 2008
The effect of entacapone on levodopa rate of absorption and latency to motor response in patients with Parkinson diseaseManuela Contin, Paolo Martinelli, Cesa Scaglione, et al.Clinical Neuropharmacology|October 7, 2008
Minocycline as adjunctive therapy for schizophrenia: an open-label studyTsuyoshi Miyaoka, Rei Yasukawa, Hideaki Yasuda, et al.Clinical Neuropharmacology|October 7, 2008
Efficacy and safety of quetiapine treatment for delusional parasitosis: experience in an elderly patientAntonio Milia, Maria G Mascia, Giuseppina Pilia, et al.Clinical Neuropharmacology|June 1, 1991
Concentrations of pravastatin and lovastatin in cerebrospinal fluid in healthy subjectsR E Botti, J Triscari, H Y Pan, et al.Pageof 236